Main > ONCOLOGY (**) > Ovarian Cancer *** > Diagnostics * > USA. V. MIA 2G Blood Test> > Description

---

Overa, a second-generation Multivariate Index Assay (MIA2G) is an FDA-cleared blood test for women with a pelvic mass who are planned for surgery. Overa (MIA2G) maintains the high level of ovarian cancer detection, across rare subtypes and including early stage cancers, afforded by OVA1 (MIA). However, Overa (MIA2G) incorporates different markers and a refined algorithm in order to improve the balance between ovarian cancer detection and healthcare efficiency. Overa (MIA2G) represents a significant improvement in positive predictive value, overall accuracy and a reduction in false positives and unnecessary referrals. With Overa (MIA2G), healthcare providers can feel confident that they are using the best tool for ovarian cancer detection while minimizing the inefficiencies to the healthcare system and patient anxiety associated with false positive results


Description's products
This section has no products